Medication Adherence in Patients with High LDL Cholesterol
The panel explores issues surrounding medication adherence and the potential for improved patient engagement. They emphasize that poor medication adherence increases the risk of cardiovascular events and discuss factors such as drug cost, timing of administration, and the importance of adopting a patient-centric approach to optimize treatment success.
EP: 1.Overview of Low-Density Lipoprotein Cholesterol Management
EP: 2.Stricter LDL-C Targets: Explaining Goalpost Changes to Patients
EP: 3.Ongoing Lp(a) Trials and Clinical Approaches to Treatment
EP: 4.Innovations in Small Interfering RNA (siRNA) Therapy
EP: 5.Optimizing PCSK9 Inhibitors and Analyzing Plaque Reduction Data
EP: 6.Evaluating Safety of Novel LDL Management Mechanism
EP: 7.Examining Results from VICTORION-INITIATE Trial
EP: 8.Other Notable Emerging Lipid-Lowering Treatments
EP: 9.REDUCE-IT Trial and Triglyceride-Lowering Agents
EP: 10.Diabetes, GLP-1, and Lipid Reduction
Now Viewing
EP: 11.Medication Adherence in Patients with High LDL Cholesterol
EP: 12.Overcoming Prior Authorization Barriers in LDL Cholesterol Therapies
EP: 13.Cardiometabolic Medicine: Seeing the Patient as a Whole
Video content above is prompted by the following questions:
- Adherence remains a big hurdle in lipid management. A well-known rule in medicine is, “the more educated the patient, the more adherent the patient.”
- How do you implement patient education on cardiovascular health into your practice? What are persistent gaps?
- How are the novel molecular treatments affecting adherence to lipid lowering therapies? (examples from your practice?)
- What is still needed on a larger/national scale to educate patients as well as providers on the importance of lipid screening and the availability of safe and effective medication?
Recent Videos
Related Content
